z-logo
Premium
Ikarugamycin: A Natural Product Inhibitor of Clathrin‐Mediated Endocytosis
Author(s) -
Elkin Sarah R.,
Oswald Nathaniel W.,
Reed Dana K.,
Mettlen Marcel,
MacMillan John B.,
Schmid Sandra L.
Publication year - 2016
Publication title -
traffic
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.677
H-Index - 130
eISSN - 1600-0854
pISSN - 1398-9219
DOI - 10.1111/tra.12425
Subject(s) - endocytosis , endocytic cycle , clathrin , biology , microbiology and biotechnology , cell culture , internalization , cell , biochemistry , genetics
Ikarugamycin ( IKA ) is a previously discovered antibiotic, which has been shown to inhibit the uptake of oxidized low‐density lipoproteins in macrophages. Furthermore, several groups have previously used IKA to inhibit clathrin‐mediated endocytosis ( CME ) in plant cell lines. However, detailed characterization of IKA has yet to be performed. Consequently, we performed biochemistry and microscopy experiments to further characterize the effects of IKA on CME . We show that IKA has an IC 50 of 2.7 μ m in H1299 cells and acutely inhibits CME , but not other endocytic pathways, in a panel of cell lines. Although long‐term incubation with IKA has cytotoxic effects, the short‐term inhibitory effects on CME are reversible. Thus, IKA can be a useful tool for probing routes of endocytic trafficking.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom